Loading...

We've got a brand new version of Simply Wall St! Try it out

AgraFlora Organics International

CNSX:AGRA
Snowflake Description

Excellent balance sheet and overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
AGRA
CNSX
CA$227M
Market Cap
  1. Home
  2. CA
  3. Pharmaceuticals & Biotech
Company description

AgraFlora Organics International Inc. operates in the cannabis industry in Canada and the Republic of Colombia. The last earnings update was 22 days ago. More info.


Add to Portfolio Compare Print
  • AgraFlora Organics International has significant price volatility in the past 3 months.
AGRA Share Price and Events
7 Day Returns
-3.7%
CNSX:AGRA
-0.2%
CA Pharmaceuticals
1.2%
CA Market
1 Year Returns
-68.3%
CNSX:AGRA
-45.8%
CA Pharmaceuticals
-0.4%
CA Market
AGRA Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
AgraFlora Organics International (AGRA) -3.7% -3.7% -39.5% -68.3% 15.6% -
CA Pharmaceuticals -0.2% -1.8% -21.5% -45.8% 251% 334.4%
CA Market 1.2% 3.3% 0.8% -0.4% 7.4% 4.5%
1 Year Return vs Industry and Market
  • AGRA underperformed the Pharmaceuticals industry which returned -45.8% over the past year.
  • AGRA underperformed the Market in Canada which returned -0.4% over the past year.
Price Volatility
AGRA
Industry
5yr Volatility vs Market

Value

 Is AgraFlora Organics International undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for AgraFlora Organics International. This is due to cash flow or dividend data being unavailable. The share price is CA$0.26.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for AgraFlora Organics International's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are AgraFlora Organics International's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:AGRA PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in CAD CA$-0.06
CNSX:AGRA Share Price ** CNSX (2019-09-19) in CAD CA$0.26
Canada Pharmaceuticals Industry PE Ratio Median Figure of 13 Publicly-Listed Pharmaceuticals Companies 18.72x
Canada Market PE Ratio Median Figure of 540 Publicly-Listed Companies 14.11x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of AgraFlora Organics International.

CNSX:AGRA PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:AGRA Share Price ÷ EPS (both in CAD)

= 0.26 ÷ -0.06

-4.7x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • AgraFlora Organics International is loss making, we can't compare its value to the CA Pharmaceuticals industry average.
  • AgraFlora Organics International is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does AgraFlora Organics International's expected growth come at a high price?
Raw Data
CNSX:AGRA PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -4.7x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Canada Pharmaceuticals Industry PEG Ratio Median Figure of 7 Publicly-Listed Pharmaceuticals Companies 1.57x
Canada Market PEG Ratio Median Figure of 246 Publicly-Listed Companies 0.95x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for AgraFlora Organics International, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on AgraFlora Organics International's assets?
Raw Data
CNSX:AGRA PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in CAD CA$0.12
CNSX:AGRA Share Price * CNSX (2019-09-19) in CAD CA$0.26
Canada Pharmaceuticals Industry PB Ratio Median Figure of 151 Publicly-Listed Pharmaceuticals Companies 2.32x
Canada Market PB Ratio Median Figure of 2,454 Publicly-Listed Companies 1.44x
CNSX:AGRA PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:AGRA Share Price ÷ Book Value per Share (both in CAD)

= 0.26 ÷ 0.12

2.15x

* Primary Listing of AgraFlora Organics International.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • AgraFlora Organics International is good value based on assets compared to the CA Pharmaceuticals industry average.
X
Value checks
We assess AgraFlora Organics International's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. AgraFlora Organics International has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is AgraFlora Organics International expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as AgraFlora Organics International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
110.6%
Expected Pharmaceuticals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is AgraFlora Organics International expected to grow at an attractive rate?
  • Unable to compare AgraFlora Organics International's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare AgraFlora Organics International's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare AgraFlora Organics International's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
CNSX:AGRA Future Growth Rates Data Sources
Data Point Source Value (per year)
Canada Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 110.6%
Canada Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 58.6%
Canada Market Earnings Growth Rate Market Cap Weighted Average 12.8%
Canada Market Revenue Growth Rate Market Cap Weighted Average 5.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:AGRA Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:AGRA Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-06-30 -9 -21
2019-03-31 -4 -10
2018-12-31 -3 -6
2018-09-30 -4 -7
2018-06-30 -2 -5
2018-03-31 -2 -4
2017-12-31 -2 -2
2017-09-30 0 -2 -2
2017-06-30 0 -1 -3
2017-03-31 0 -1 -2
2016-12-31 0 0 -2
2016-09-30 0 0 -1

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if AgraFlora Organics International is high growth as no earnings estimate data is available.
  • Unable to determine if AgraFlora Organics International is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:AGRA Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from AgraFlora Organics International Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:AGRA Past Financials Data
Date (Data in CAD Millions) EPS *
2019-06-30 -0.06
2019-03-31 -0.03
2018-12-31 -0.02
2018-09-30 -0.02
2018-06-30 -0.02
2018-03-31 -0.02
2017-12-31 -0.01
2017-09-30 -0.01
2017-06-30 -0.01
2017-03-31 -0.01
2016-12-31 -0.01
2016-09-30 -0.01

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if AgraFlora Organics International will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine AgraFlora Organics International's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. AgraFlora Organics International's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Pharmaceuticals & Biotech companies here
  3. AgraFlora Organics International's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess AgraFlora Organics International's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
AgraFlora Organics International has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has AgraFlora Organics International performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare AgraFlora Organics International's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • AgraFlora Organics International does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare AgraFlora Organics International's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare AgraFlora Organics International's 1-year growth to the CA Pharmaceuticals industry average as it is not currently profitable.
Earnings and Revenue History
AgraFlora Organics International's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from AgraFlora Organics International Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:AGRA Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 -20.81 20.25 0.08
2019-03-31 -9.72 8.18 0.08
2018-12-31 -5.74 5.34 0.08
2018-09-30 -6.61 6.18 0.11
2018-06-30 -5.24 5.12 0.08
2018-03-31 -4.27 4.30 0.06
2017-12-31 -2.04 2.09 0.07
2017-09-30 0.00 -2.42 1.09 0.26
2017-06-30 0.14 -2.60 1.30 0.25
2017-03-31 0.00 -2.43 1.20 0.23
2016-12-31 0.14 -2.04 0.90 0.21
2016-09-30 0.14 -1.30 1.07
2016-06-30 0.00 -0.97 0.67
2016-03-31 0.15 -1.43 1.10
2015-12-31 0.01 -1.45 1.06
2015-09-30 0.01 -0.99 0.91
2015-06-30 0.01 -1.08 1.07
2015-03-31 -0.84 0.83
2014-12-31 -1.15 1.13
2014-09-30 -2.70 1.07
2014-06-30 -2.52 0.85
2014-03-31 -2.30 0.65
2013-12-31 -1.99 0.34
2013-09-30 -0.30 0.34
2013-06-30 -0.23 0.31
2013-03-31 -0.28 0.37
2012-12-31 -0.32 0.40
2012-09-30 -0.43 0.53

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if AgraFlora Organics International has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if AgraFlora Organics International has efficiently used its assets last year compared to the CA Pharmaceuticals industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if AgraFlora Organics International improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess AgraFlora Organics International's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
AgraFlora Organics International has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is AgraFlora Organics International's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up AgraFlora Organics International's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • AgraFlora Organics International is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • AgraFlora Organics International has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of AgraFlora Organics International's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • AgraFlora Organics International has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from AgraFlora Organics International Company Filings, last reported 2 months ago.

CNSX:AGRA Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 59.32 0.00 14.41
2019-03-31 50.58 0.00 29.52
2018-12-31 29.67 0.00 10.74
2018-09-30 6.63 0.40 1.36
2018-06-30 7.61 0.39 3.27
2018-03-31 7.42 0.23 3.67
2017-12-31 7.57 0.64 4.10
2017-09-30 3.71 0.00 2.03
2017-06-30 3.60 0.00 1.89
2017-03-31 3.39 0.00 2.20
2016-12-31 1.44 0.00 0.50
2016-09-30 2.11 0.00 0.16
2016-06-30 1.87 0.00 0.01
2016-03-31 1.94 0.00 0.09
2015-12-31 1.97 1.51 0.13
2015-09-30 1.52 1.45 0.08
2015-06-30 1.74 1.35 0.46
2015-03-31 0.74 0.13 0.03
2014-12-31 0.51 0.00 0.09
2014-09-30 0.63 0.06 0.40
2014-06-30 0.12 0.00 0.01
2014-03-31 0.20 0.01 0.11
2013-12-31 -0.25 0.34 0.01
2013-09-30 1.43 0.28 0.00
2013-06-30 1.57 0.18 0.00
2013-03-31 1.65 0.13 0.01
2012-12-31 1.72 0.03 0.08
2012-09-30 1.47 0.00 0.01
  • AgraFlora Organics International has no debt.
  • AgraFlora Organics International has no debt compared to 5 years ago when it was 0.5%.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • AgraFlora Organics International has sufficient cash runway for 1.4 years based on current free cash flow.
  • Unable to confirm if AgraFlora Organics International has at least 1 year of cash runway based on growing free cash flows without relevant data.
X
Financial health checks
We assess AgraFlora Organics International's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. AgraFlora Organics International has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is AgraFlora Organics International's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from AgraFlora Organics International dividends.
If you bought CA$2,000 of AgraFlora Organics International shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate AgraFlora Organics International's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate AgraFlora Organics International's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:AGRA Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
North America Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 2.8%
Canada Market Average Dividend Yield Market Cap Weighted Average of 334 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.2%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as AgraFlora Organics International has not reported any payouts.
  • Unable to verify if AgraFlora Organics International's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of AgraFlora Organics International's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as AgraFlora Organics International has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess AgraFlora Organics International's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can AgraFlora Organics International afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. AgraFlora Organics International has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of AgraFlora Organics International's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Brandon Boddy
AGE 35
TENURE AS CEO 0.3 years
CEO Bio

Mr. Brandon Boddy has been Chairman and Chief Executive Officer at Applied Energetics, Inc. since May21, 2019. Mr. Boddy has been a Director of Bee Vectoring Technologies International Inc. since April 25, 2018. Mr. Boddy served as Chief Executive Officer and Director of Tiller Resources Ltd. from September 13, 2016 to february 2017. Mr. Boddy has been a Director of AgraFlora Organics International Inc. since April 23, 2019. Mr. Boddy served as Chief Executive Officer of Opal Energy Corp until May 2016. Mr. Boddy is a founding Director of Global Blockchain Technologies Corp. He serves as President of Boddy and Co. Investments Ltd. Mr. Boddy served as an Investment Advisor of Jordan Capital Markets Inc. from 2006 to 2014. Mr. Boddy served as Director at Auxly Cannabis Group Inc. until December 27, 2018. Mr. Boddy served as Senior Vice President at Canaccord Capital Corp. From 2006 to 2014, he served as Vice President at Canaccord Financial Inc., as well as Principal and Senior Vice President at Jordan Capital Markets. He contributes 14 years of capital markets experience and directly as a Principal. He was an Independent Director of Global Blockchain Technologies (f/k/a Carrus Capital Corporation) since January 27, 2017 until October 10, 2017. Mr. Boddy has been a Director of Cannabis Wheaton Income Corp. since December 21, 2016. He has been a Director of Knightswood Financial Corp. since December 2016. Mr. Boddy serves on the Board of a number of public technology and resource issuers. He served as a Director of ALQ Gold Corp. since August 3, 2017 until February 22, 2019. He served as a Director of Pantheon Ventures Ltd. since February 12, 2015. He served as a Director of Moovly Media Inc., until June 2018. Mr. Boddy served as a Director of Versus Systems Inc. since January 22, 2015 until June 30, 2016. Mr. Boddy attended the University of New Orleans and studied Business Administration and finished his Degree at British Columbia Institute of Technology.

CEO Compensation
  • Insufficient data for Brandon to compare compensation growth.
  • Insufficient data for Brandon to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
Management Team Tenure

Average tenure of the AgraFlora Organics International management team in years:

0.4
Average Tenure
  • The average tenure for the AgraFlora Organics International management team is less than 2 years, this suggests a new team.
Management Team

Derek Lloyd Ivany

TITLE
Consultant
COMPENSATION
CA$1M
TENURE
0.3 yrs

Brandon Boddy

TITLE
Chairman & CEO
AGE
35
TENURE
0.3 yrs

Peter Nguyen

TITLE
Chief Financial Officer
TENURE
0.3 yrs

Peter Karroll

TITLE
Director of Branding & Marketing
TENURE
2.7 yrs

Zbigniew Szybinski

TITLE
Vice President of Exploration
TENURE
12.7 yrs

Jan Urata

TITLE
Corporate Secretary
TENURE
0.4 yrs
Board of Directors Tenure

Average tenure and age of the AgraFlora Organics International board of directors in years:

4.5
Average Tenure
44
Average Age
  • The tenure for the AgraFlora Organics International board of directors is about average.
Board of Directors

Brandon Boddy

TITLE
Chairman & CEO
AGE
35
TENURE
0.3 yrs

C. Rebagliati

TITLE
Member of the Advisory Board
TENURE
12.3 yrs

Al Korelin

TITLE
Member of the Advisory Board
COMPENSATION
CA$19K
AGE
75
TENURE
11.6 yrs

Piotr Lutynski

TITLE
Member of the Advisory Board
TENURE
10.8 yrs

Ian Flint

TITLE
Member of Advisory Board
COMPENSATION
CA$27K
TENURE
6.7 yrs

Chris Hornung

TITLE
Independent Director
COMPENSATION
CA$65K
AGE
44
TENURE
5.6 yrs

Jerry Habuda

TITLE
Director
COMPENSATION
CA$65K
TENURE
3.3 yrs

Joseph Perino

TITLE
Director
COMPENSATION
CA$65K
TENURE
3 yrs

Brent Wickens

TITLE
Member of Advisory Board
TENURE
3 yrs

Cezar Khursigara

TITLE
Member of Advisory Board
TENURE
1.4 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
12. Jul 19 Buy Organic Flower Investments Group Inc. Company 11. Jul 19 11. Jul 19 348,109,251 CA$0.40 CA$139,243,919
25. Mar 19 Sell Elben Capital Corp. Company 13. Mar 19 20. Mar 19 -5,500,000 CA$0.69 CA$-3,194,274
22. Mar 19 Sell Christopher Hornung Individual 19. Mar 19 19. Mar 19 -100,000 CA$0.64 CA$-64,000
20. Mar 19 Sell Joseph Perino Individual 19. Mar 19 19. Mar 19 -50,000 CA$0.59 CA$-29,500
14. Mar 19 Sell Christopher Hornung Individual 08. Mar 19 08. Mar 19 -150,000 CA$0.53 CA$-79,500
04. Mar 19 Sell Christopher Hornung Individual 27. Feb 19 01. Mar 19 -350,000 CA$0.40 CA$-138,317
25. Feb 19 Sell Christopher Hornung Individual 21. Feb 19 21. Feb 19 -50,000 CA$0.30 CA$-14,750
08. Feb 19 Sell Elben Capital Corp. Company 04. Feb 19 08. Feb 19 -1,000,000 CA$0.32 CA$-310,375
29. Jan 19 Sell Christopher Hornung Individual 25. Jan 19 25. Jan 19 -250,000 CA$0.29 CA$-71,665
08. Jan 19 Sell Christopher Hornung Individual 04. Jan 19 04. Jan 19 -95,000 CA$0.32 CA$-30,400
04. Jan 19 Sell Joseph Perino Individual 04. Jan 19 04. Jan 19 -100,000 CA$0.32 CA$-32,000
20. Dec 18 Buy Christopher Hornung Individual 18. Dec 18 18. Dec 18 1,493,325 CA$0.17 CA$248,936
17. Dec 18 Sell Christopher Hornung Individual 13. Dec 18 13. Dec 18 -330,000 CA$0.21 CA$-68,340
10. Oct 18 Sell Joseph Perino Individual 09. Oct 18 09. Oct 18 -12,000 CA$0.00 CA$-12
09. Oct 18 Sell Joseph Perino Individual 05. Oct 18 05. Oct 18 -7,600 CA$1.22 CA$-9,272
X
Management checks
We assess AgraFlora Organics International's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. AgraFlora Organics International has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Should You Be Worried About Insider Transactions At AgraFlora Organics International Inc. (CNSX:AGRA)?

So we'll take a look at whether insiders have been buying or selling shares in AgraFlora Organics International Inc. … Check out our latest analysis for AgraFlora Organics International AgraFlora Organics International Insider Transactions Over The Last Year Over the last year, we can see that the biggest insider purchase was by Independent Director Christopher Hornung for CA$249k worth of shares, at about CA$0.17 per share. … All up, insiders sold more shares in AgraFlora Organics International than they bought, over the last year.

Simply Wall St -

How Does AgraFlora Organics International Inc. (CNSX:AGRA) Affect Your Portfolio Volatility?

(CNSX:AGRA), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. … Beta is a widely used metric to measure a stock's exposure to market risk (volatility). … Any stock with a beta of greater than one is considered more volatile than the market, while those with a beta below one are either less volatile or poorly correlated with the market.

Simply Wall St -

Company Info

Description

AgraFlora Organics International Inc. operates in the cannabis industry in Canada and the Republic of Colombia. The company was formerly known as PUF Ventures Inc. and changed its name to AgraFlora Organics International Inc. in November 2018. AgraFlora Organics International Inc. was incorporated in 2004 and is headquartered in Vancouver, Canada.

Details
Name: AgraFlora Organics International Inc.
AGRA
Exchange: CNSX
Founded: 2004
CA$227,085,528
873,405,880
Website: http://www.agraflora.com
Address: AgraFlora Organics International Inc.
750 West Pender Street,
Suite 804,
Vancouver,
British Columbia, V6C 2T7,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX AGRA Common Shares Canadian National Stock Exchange CA CAD 01. Mar 2006
DB PU31 Common Shares Deutsche Boerse AG DE EUR 01. Mar 2006
Number of employees
Current staff
Staff numbers
0
AgraFlora Organics International employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/09/20 01:13
End of day share price update: 2019/09/19 00:00
Last earnings filing: 2019/08/29
Last earnings reported: 2019/06/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.